CDT Equity Inc. (CDT)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Aug. 5, 2025 | CORRESP | Neutral/Informational | Moderate | Conduit Pharmaceuticals Inc. has submitted a request to the U.S. Securities and Exchange Commission to expedite the effectiveness of their Registration Statement on Form S-3. They… | Read Filing EDGAR |
| Aug. 5, 2025 | UPLOAD | Neutral/Informational | Low | The SEC correspondence dated August 5, 2025, informs Conduit Pharmaceuticals Inc. that their registration statement on Form S-3, filed on July 31, 2025, will not be reviewed by th… | Read Filing EDGAR |
| Apr. 28, 2025 | CORRESP | Neutral/Informational | Moderate | Conduit Pharmaceuticals Inc. has submitted a request to the U.S. Securities and Exchange Commission to expedite the effectiveness of their Registration Statement on Form S-3. They… | Read Filing EDGAR |
| Apr. 28, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Conduit Pharmaceuticals Inc. that it will not review their registration statement filed on April 22, 2025. The letter emphasizes the company's responsi… | Read Filing EDGAR |